Integration of gut microbiota metabolites, NOD2-related inflammatory network, and medicinal food homologous plants identifies IL1B and MMP1 as key targets in Crohn’s disease
Journal of Pharmacy and Pharmacology · 04.11.2026 · 78 (11)
DOI: 10.1093/jpp/rgag145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 14.11.2026. Verfasst von Zimo Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology, Shandong Second Medical University, Weifang, Shandong 261053, China. Hauptthemen laut MEDLINE: Crohn Disease, Gastrointestinal Microbiome, Nod2 Signaling Adaptor Protein, Interleukin-1beta. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
Crohn’s disease is a chronic inflammatory bowel disease associated with gut microbiota imbalance and immune dysregulation. This study aimed to identify candidate key protein targets of Crohn’s disease and explore candidate therapeutic compounds derived from gut microbiota metabolites and medicinal plants.
Methods
Gene expression data from Crohn’s disease patients were obtained from public databases. Hub targets of gut microbiota metabolites were retrieved from the gutMGene database, and NOD2-related genes were obtained from GeneCards. Differentially expressed genes were identified using machine learning combined with feature attribution analysis. Subcellular localization and external datasets were used for validation. Drug-likeness and toxicity of microbial metabolites were assessed, and active compounds from medicinal plants were predicted via database mining and validated by molecular docking. Key findings Interleukin-1 beta and matrix metalloproteinase-1 were identified as key genes. Seven gut microbiota-derived metabolites showed favourable drug-likeness without predicted carcinogenicity or hepatotoxicity. Several compounds from Panax ginseng and Scutellaria baicalensis exhibited strong binding affinity to the target proteins.
Conclusions
Interleukin-1 beta and matrix metalloproteinase-1 are candidate key proteins in Crohn’s disease and are associated with the NOD2-related downstream inflammatory network, including nuclear factor kappa-B signalling. Gut microbiota metabolites may influence this network and represent candidate molecules for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science and Technology, Shandong Second Medical University, Weifang, Shandong 261053, China.
- College of Foreign Languages, Shandong Second Medical University, Weifang, Shandong 261053, China.
- Department of Thoracic Surgery, Weifang People's Hospital, Weifang, Shandong 261041, China.
- School of Basic Medical Science, Shandong Second Medical University, Weifang, Shandong 261053, China.
ORCID-Profile: Zimo Wang
Zitieren
APA
Wang, Z., You, Y., Song, X., Yuan, T., Zhang, Z., & Liu, P. (2026). Integration of gut microbiota metabolites, NOD2-related inflammatory network, and medicinal food homologous plants identifies IL1B and MMP1 as key targets in Crohn’s disease. Journal of Pharmacy and Pharmacology, 78(11). https://doi.org/10.1093/jpp/rgag145
Vancouver
Wang Z, You Y, Song X, Yuan T, Zhang Z, Liu P. Integration of gut microbiota metabolites, NOD2-related inflammatory network, and medicinal food homologous plants identifies IL1B and MMP1 as key targets in Crohn’s disease. Journal of Pharmacy and Pharmacology. 2026;78(11). doi:10.1093/jpp/rgag145
BibTeX
@article{Wang2026,
author = {Wang, Zimo and You, Yinghui and Song, Xinxia and Yuan, Tangyu and Zhang, Zhenjiang and Liu, Pengtao},
title = {Integration of gut microbiota metabolites, NOD2-related inflammatory network, and medicinal food homologous plants identifies IL1B and MMP1 as key targets in Crohn’s disease},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {11},
doi = {10.1093/jpp/rgag145}
}
EUVIMED